DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Diarrhoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Diarrhoea (127)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 127   Next >>

Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient: female, weighing 69.6 kg (153.2 pounds)

Reactions: Vomiting, Metabolic Acidosis, Diarrhoea, Nausea, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Pertuzumab
    Indication: Breast Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Docetaxel
    Indication: Breast Cancer
    Start date: 2012-06-18
    End date: 2012-06-18

Other drugs received by patient: Neulasta; Taxol



Possible Herceptin side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20

Patient:

Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: arm b
    Administration route: Oral
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer

Lapatinib
    Dosage: arm c
    Administration route: Oral

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer

Herceptin
    Dosage: maintenance dose

Fluorouracil
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-15

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: permanently discontinued
    End date: 2012-05-25

Docetaxel
    Dosage: permanently discontinued
    End date: 2012-05-25

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-25

Docetaxel
    Dosage: permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Carboplatin
    Dosage: permanently discontinued
    End date: 2012-05-25

Herceptin
    Dosage: maintanance dose, temporarily interrupted
    End date: 2012-05-04

Carboplatin
    Dosage: temporarily discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Herceptin
    Dosage: loading dose, permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13

Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran



Possible Herceptin side effects in 73 year old male

Reported by a pharmacist from Japan on 2012-08-15

Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Pruritus, Respiratory Failure, Diarrhoea, Anaemia, Infusion Related Reaction

Drug(s) suspected as cause:
Herceptin
    Dosage: 8mg/kg
    Indication: Metastatic Gastric Cancer
    Start date: 2012-07-04
    End date: 2012-07-04

Xeloda
    Administration route: Oral
    Indication: Metastatic Gastric Cancer
    Start date: 2012-07-04
    End date: 2012-07-04

Other drugs received by patient: Lansoprazole; Ferrous Citrate; Maglax; Alloid G; Acetaminophen; Promac; Hochuekkito



Possible Herceptin side effects in

Reported by a physician from Taiwan, Province of China on 2012-08-14

Patient:

Reactions: Hypersensitivity, Vomiting, Nausea, Diarrhoea, Alopecia, Anaemia

Drug(s) suspected as cause:
Herceptin
    Dosage: loading dose, over 90 min on day 1, 1st cycle
    Indication: Breast Cancer

Herceptin
    Dosage: for 30 min on days 8 and 15, 1st cycle

Docetaxel
    Dosage: on day 1, 1st cycle
    Indication: Breast Cancer

Cisplatin
    Dosage: for 24hours 1st cycle
    Indication: Breast Cancer

Other drugs received by patient: Dexamethasone



Possible Herceptin side effects in 73 year old male

Reported by a pharmacist from Japan on 2012-08-13

Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Pruritus, Diarrhoea, Respiratory Failure, Anaemia, Infusion Related Reaction

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Metastatic Gastric Cancer
    Start date: 2012-07-04
    End date: 2012-07-04

Herceptin
    Dosage: 8mg/kg
    Indication: Metastatic Gastric Cancer
    Start date: 2012-07-04
    End date: 2012-07-04

Other drugs received by patient: Hochuekkito; Alloid G; Acetaminophen; Lansoprazole; Maglax; Promac; Ferrous Citrate



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: female, weighing 64.9 kg (142.8 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Vomiting, Gastrointestinal Haemorrhage, Nausea, Hyponatraemia, Hypokalaemia, Haemoglobin Decreased, Diarrhoea, Dehydration, Hypocalcaemia, Neutrophil Count Decreased, Blood Creatinine Increased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: 139 milligram
    Start date: 2012-07-18

Abraxane
    Dosage: 177 milligram
    Start date: 2012-07-18
    End date: 2012-07-25

Herceptin
    Dosage: 139 milligram
    Indication: Breast Cancer
    Start date: 2012-06-13

Abraxane
    Dosage: 80 microgram/sq. meter
    Start date: 2012-08-01

Carboplatin
    Dosage: 675 milligram
    Indication: Breast Cancer
    Start date: 2012-06-13

Carboplatin
    Dosage: 675 milligram
    Start date: 2012-07-18

Abraxane
    Dosage: 177 milligram
    Indication: Breast Cancer
    Start date: 2012-06-13

Other drugs received by patient: Dexamethasone; Gabapentin; Ativan; Motrin; Ativan; Vicodin; Ativan; Ativan



Possible Herceptin side effects in female

Reported by a physician from United Kingdom on 2012-08-07

Patient: female, weighing 93.7 kg (206.0 pounds)

Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae: 29 july 2011, last dose 546 mg

Docetaxel
    Dosage: dose decreased, date of last dose prior to sae: 11/nov/2011
    Indication: Breast Cancer

Docetaxel
    Dosage: dose decreased,last dose on 29 july 2011, last dose taken 75 mg
    Start date: 2011-07-29
    End date: 2011-11-11

Herceptin
    Dosage: dose held.
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-19

Patient: female

Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer

Herceptin
    Indication: Breast Cancer

Xeloda
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-19

Patient: female, weighing 57.9 kg (127.4 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Otitis Externa, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: 120 milligram
    Start date: 2012-06-05

Herceptin
    Dosage: 120 milligram
    Start date: 2012-06-12

Carboplatin
    Dosage: 720 milligram
    Indication: Breast Cancer
    Start date: 2012-04-17
    End date: 2012-06-26

Abraxane
    Dosage: 128 milligram
    Indication: Breast Cancer
    Start date: 2012-04-17
    End date: 2012-06-26

Abraxane
    Dosage: 118 milligram

Herceptin
    Dosage: 2 milligram
    Start date: 2012-05-29

Other drugs received by patient: Ciprofloxacin; Zofran; Neurontin; Protonix; Colace; Lovenox; Neurontin; Neupogen; Ciprofloxacin; Atenolol; Zolpidem; Magnesium Sulfate; Imodium; K-TAB; Vicodin; Zosyn; Zofran; Vancomycin; Levaquin; Morphine Sulfate; Ciprofloxacin HCL; Augmentin '500'; Acyclovir



Possible Herceptin side effects in female

Reported by a physician from Spain on 2012-07-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Pertuzumab
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Herceptin
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Docetaxel
    Dosage: last dose prior to sae:11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-04-30

Blinded Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Insulin; Bromazepam; Acetaminophen; Venlafaxine; Enalapril Maleate; Omeprazole; Gliclazide; Gemfibrozil; Metformin HCL; Atorvastan



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-10

Patient: female

Reactions: Tooth Loss, Weight Decreased, Primary Sequestrum, Abdominal Pain, Pruritus, Metastases To Liver, Osteomyelitis, Tooth Infection, Erythema, Pericardial Effusion, Cardiac Disorder, Asphyxia, Haemangioma of Liver, Ecchymosis, Hypoxia, Nail Disorder, Pathological Fracture, Fluid Retention, Pneumonia, Fistula, Cellulitis, Anaemia, Paraesthesia, Decreased Interest, Hepatic Cyst, Atelectasis, Exposed Bone in JAW, Pain, Hypokalaemia, Neuropathy Peripheral, Bone Loss, Chest Pain, Onychoclasis, Pleural Effusion, Depression, Injury, Thrombocytopenia, Lymphoedema, Metastases To Lung, Emphysema, Tooth Fracture, Dyspnoea, Dental Caries, Sensation of Heaviness, Rash, Hydropneumothorax, Bronchopleural Fistula, Osteonecrosis of JAW, Diarrhoea, Impaired Healing, Ejection Fraction Decreased, JAW Disorder, Sinus Tachycardia

Drug(s) suspected as cause:
Taxotere
    Dosage: 58 mg, qw

Herceptin
    Dosage: 162 mg, qw
    End date: 2007-06-11

Zometa
    Dosage: 4 mg, qmo
    Indication: Hypercalcaemia of Malignancy
    Start date: 2003-12-01
    End date: 2007-02-01

Zometa
    Indication: Breast Cancer

Zometa
    Indication: Metastases To Bone

Other drugs received by patient: Procrit; Decadron; Zofran; Coreg; Aranesp; Femara; Faslodex; Klor-CON; Torsemide; Lisinopril; Cleocin Hydrochloride; Vicodin; Adriamycin PFS; Carboplatin



Possible Herceptin side effects in 42 year old female

Reported by a physician from Poland on 2012-07-05

Patient: 42 year old female

Reactions: Diarrhoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Disease Progression

Drug(s) suspected as cause:
Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-10-17
    End date: 2008-10-08

Xeloda
    Indication: Product Used FOR Unknown Indication

Lapatinib
    Indication: Product Used FOR Unknown Indication



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-04

Patient: female

Reactions: Abdominal Pain, Weight Decreased, Tooth Loss, Primary Sequestrum, Pruritus, Metastases To Liver, Osteomyelitis, Tooth Infection, Erythema, Cardiac Disorder, Asphyxia, Pericardial Effusion, Haemangioma of Liver, Ecchymosis, Nail Disorder, Hypoxia, Pathological Fracture, Fluid Retention, Pneumonia, Cellulitis, Fistula, Anaemia, Decreased Interest, Paraesthesia, Atelectasis, Exposed Bone in JAW, Pain, Bone Loss, Neuropathy Peripheral, Chest Pain, Onychoclasis, Pleural Effusion, Depression, Injury, Thrombocytopenia, Metastases To Lung, Emphysema, Dyspnoea, Tooth Fracture, Dental Caries, Sensation of Heaviness, Rash, Hydropneumothorax, Bronchopleural Fistula, Diarrhoea, Osteonecrosis of JAW, Impaired Healing, Ejection Fraction Decreased, JAW Disorder, Sinus Tachycardia

Drug(s) suspected as cause:
Zometa
    Dosage: 4 mg, qmo
    Indication: Hypercalcaemia of Malignancy
    Start date: 2003-12-01
    End date: 2007-02-01

Zometa
    Indication: Breast Cancer

Herceptin
    Dosage: 162 mg, qw
    End date: 2007-06-11

Taxotere
    Dosage: 58 mg, qw

Zometa
    Indication: Metastases To Bone

Other drugs received by patient: Lisinopril; Torsemide; Decadron; Femara; Zofran; Coreg; Aranesp; Cleocin Hydrochloride; Klor-CON; Procrit; Faslodex; Adriamycin PFS; Carboplatin; Vicodin



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Spain on 2012-07-02

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Pertuzumab
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Blinded Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: maintanance dose, last dose prior to sae:11/jun/2012

Docetaxel
    Dosage: last dose prior to sae:11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Paracetamol; Omeprazole; Enalapril Maleate; Gemfibrozil; Insulin; Atorvastan; Bromazepam; Metformin HCL; Gliclazide; Loperamide; Venlafaxine



Possible Herceptin side effects in 77 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-22

Patient: 77 year old female

Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-14

Cisplatin
    Indication: Breast Cancer
    Start date: 2012-02-08

Cisplatin
    Indication: Gastric Cancer
    Start date: 2012-02-08

Cisplatin
    Start date: 2012-02-29

Herceptin
    Indication: Gastric Cancer
    Start date: 2012-02-08
    End date: 2012-02-29

Cisplatin
    Start date: 2012-02-29

Emend
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-03-02

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-02-08
    End date: 2012-02-22

Emend
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-02-08
    End date: 2012-03-02

Xeloda
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-02-08
    End date: 2012-02-22

Xeloda
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-14

Herceptin
    Indication: Breast Cancer
    Start date: 2012-02-08
    End date: 2012-02-29

Other drugs received by patient: Iperten; Allopurinol; Xenetix; Lovenox; Magnesium Sulfate; Cordarone; Bisoprolol Fumarate and Hydrochlorothiazide; Lorazepam; Potassium Chloride; Nexium; Acetaminophen; Tramadol HCL; Zofran



Possible Herceptin side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-19

Patient:

Reactions: Thrombosis, Headache, Device Related Infection, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hypotension, Anaemia, Hyperglycaemia, Dehydration, Neutropenia, Pain, Bone Pain, Hypokalaemia, Neutropenic Infection, Postoperative Wound Infection, Fatigue, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Lymphopenia, Alanine Aminotransferase Increased, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Arthralgia, Diarrhoea, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection

Drug(s) suspected as cause:
Vinorelbine Tartrate
    Dosage: on day 8 and 15 of the 21 days cycle
    Indication: Breast Cancer Metastatic

Herceptin

Docetaxel
    Indication: Breast Cancer Metastatic

Herceptin
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in 77 year old female

Reported by a physician from France on 2012-06-15

Patient: 77 year old female

Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Start date: 2012-02-29

Xeloda
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-02-08
    End date: 2012-02-22

Xeloda
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-14

Herceptin
    Start date: 2012-02-29

Emend
    Dosage: on day 1, 2 and 3 of 14 day cycle
    Indication: Vomiting
    Start date: 2012-02-08
    End date: 2012-03-02

Herceptin
    Indication: Gastric Cancer
    Start date: 2012-02-08
    End date: 2012-02-29

Cisplatin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-08
    End date: 2012-02-29

Other drugs received by patient: Iperten; Nexium; Allopurinol; Xenetix; Bisoprolol Fumarate and Hydrochlorothiazide; Lovenox; Kaleorid LP; Zofran; Lorazepam; Acetaminophen; Tramadol HCL; Cordarone



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-13

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Vomiting, Diarrhoea, Ileus, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: most recent dose: 17/may/2012, last dose: 282mg
    Indication: Gastric Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: dose reduced

Pertuzumab
    Dosage: date of most recent dose of prior to ae:17/may/2012, last dose: 420mg
    Indication: Gastric Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: last dose prior to ae onset: 17/may/2012, last dose: 60mg/m2
    Indication: Gastric Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: on 31 may 2012, the patient received last dose prior to adverse event, last dose taken: 750 mg/m2
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-03-29

Other drugs received by patient: Clarithromycin



Possible Herceptin side effects in female

Reported by a physician from Korea, Republic of on 2012-06-11

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Vomiting, Viral Infection, Ileus, Diarrhoea, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pertuzumab
    Dosage: date of most recent dose of prior to ae:17/may/2012, last dose: 420mg
    Indication: Gastric Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: on 31 may 2012, the patient received last dose prior to adverse event, last dose taken: 750 mg/m2
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: last dose prior to ae onset: 17/may/2012, last dose: 60mg/m2
    Indication: Gastric Cancer
    Start date: 2012-03-29

Herceptin
    Dosage: most recent dose: 17/may/2012, last dose: 282mg
    Indication: Gastric Cancer
    Start date: 2012-03-29

Other drugs received by patient: Clarithromycin



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-08

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Vomiting, Ileus, Diarrhoea, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pertuzumab
    Dosage: date of most recent dose of prior to ae:17/may/2012, last dose: 420mg
    Indication: Gastric Cancer
    Start date: 2012-03-29

Xeloda
    Dosage: date of most recent dose of prior to ae: 17/may/2012, last dose taken: 750 mg/m2
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-03-29

Cisplatin
    Dosage: last dose prior to ae onset: 17/may/2012, last dose: 60mg/m2
    Indication: Gastric Cancer
    Start date: 2012-03-29

Herceptin
    Dosage: most recent dose: 17/may/2012, last dose: 282mg
    Indication: Gastric Cancer
    Start date: 2012-03-29



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United Kingdom on 2012-06-08

Patient: female, weighing 93.0 kg (204.6 pounds)

Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae: 29 july 2011, last dose 546 mg

Docetaxel
    Dosage: dose decreased,last dose on 29 july 2011, last dose taken 75 mg
    Start date: 2011-07-29
    End date: 2011-11-11

Docetaxel
    Dosage: dose decreased,
    Indication: Breast Cancer

Herceptin
    Dosage: dose held.
    Indication: Breast Cancer



Possible Herceptin side effects in

Reported by a individual with unspecified qualification from Italy on 2012-06-05

Patient:

Reactions: Vomiting, Nausea, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Diarrhoea, Neutropenia, Asthenia, Leukopenia, Deep Vein Thrombosis

Drug(s) suspected as cause:
Herceptin
    Dosage: loading dose on day 1 of each cycle
    Indication: Breast Cancer

Pegylated Liposomal Doxorubicin
    Dosage: on day 1
    Indication: Breast Cancer

Fluorouracil
    Dosage: 200 mg/m2 as a continuous infusion from day 1 through day 21 to be repeated every 21 days for 8 cour
    Indication: Breast Cancer

Herceptin
    Dosage: on day 2 of each cycle

Cisplatin
    Dosage: on day 1
    Indication: Breast Cancer



Possible Herceptin side effects in 60 year old female

Reported by a individual with unspecified qualification from United States on 2012-06-01

Patient: 60 year old female, weighing 79.7 kg (175.3 pounds)

Reactions: Fatigue, Diarrhoea, Dehydration, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tarceva
    Administration route: Oral
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Herceptin
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-05-31

Patient: female

Reactions: Diarrhoea, Dehydration, Hypotension, Vision Blurred, Hypoxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: over 90 min on day 1, week 1 only
    Indication: Breast Cancer
    Start date: 2005-08-17

Carboplatin
    Dosage: auc 2,over 1 hour on days 1,8 and 15.
    Indication: Breast Cancer
    Start date: 2005-08-17

Metoprolol Succinate
    Indication: Product Used FOR Unknown Indication

Lorazepam
    Indication: Product Used FOR Unknown Indication

Herceptin
    Dosage: over 90 min on day 1,maintenance therapy

Epothilone NOS
    Dosage: over 1 hour on days 1,8 and 15
    Indication: Breast Cancer
    Start date: 2005-08-17

Amlodipine
    Indication: Product Used FOR Unknown Indication

Herceptin
    Dosage: over 30 min on day1,8 ,15and 22 starting on week 2



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-31

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Diarrhoea, Disseminated Intravascular Coagulation, Sepsis, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Docetaxel
    Dosage: temporarily interrupted
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Herceptin
    Dosage: loading dose, temporarily interrupted
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-04-13

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13

Other drugs received by patient: Zofran; Lovaza; Tylenol; Clindamycin



Possible Herceptin side effects in female

Reported by a physician from United Kingdom on 2012-05-29

Patient: female, weighing 93.0 kg (204.6 pounds)

Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: dose held.
    Indication: Breast Cancer

Docetaxel
    Dosage: dose decreased,
    Indication: Breast Cancer

Docetaxel
    Dosage: dose decreased,last dose on 29 july 2011

Herceptin
    Dosage: last dose prior to sae: 29 july 2011



Possible Herceptin side effects in female

Reported by a physician from United Kingdom on 2012-05-28

Patient: female, weighing 93.0 kg (204.6 pounds)

Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: dose held.
    Indication: Breast Cancer

Herceptin
    Dosage: last dose prior to sae: 29 july 2011

Docetaxel
    Dosage: dose decreased,last dose on 29 july 2011

Docetaxel
    Dosage: dose decreased,
    Indication: Breast Cancer



Possible Herceptin side effects in 65 year old female

Reported by a consumer/non-health professional from United States on 2012-05-28

Patient: 65 year old female, weighing 81.7 kg (179.8 pounds)

Reactions: Oropharyngeal Pain, Dysgeusia, Weight Increased, Fatigue, Diarrhoea, Swelling, DRY Mouth, Ejection Fraction Decreased

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Flagyl; Taxotere; Hydrochlorothiazide; Vancomycin



Possible Herceptin side effects in male

Reported by a physician from Canada on 2012-05-24

Patient: male

Reactions: Diarrhoea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Metastatic Gastric Cancer
    Start date: 2011-10-31

Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-01
    End date: 2012-02-01

Cisplatin
    Indication: Metastatic Gastric Cancer

Other drugs received by patient: Diovan



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014